Food and Drugs Administration, (FDA) Haryana, India. |
Email ID: dahiya19@yahoo.com
- Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation - December 11, 2024
- Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene - December 9, 2024
- Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management - December 5, 2024
Last Updated on October 10, 2024 by The Health Master
Indian Pharmacopoeia Commission (IPC) issues alerts from time to time regarding various drugs. We have provided these IPC alerts:
Click the below links to read the full details:
IPC alerts about Cefoperazone induced coagulopathy
IPC flags safety alert against immunosuppressive drug Tacrolimus
IPC flags safety alert against Blood Pressure drug, Losartan
IPC flags safety alert against most common Drug Ibuprofen – NSAID
IPC flags safety alert against Covid-19 drug Remdesivir
IPC flags safety alert against NSAID Diclofenac
IPC flags safety alert against Dimethyl Fumarate & Cefazolin
Safety alert against Hepatitis C drug Sofosbuvir: IPC
Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Latest Notifications regarding Pharmaceuticals
For other Notifications / Notices / Circulars by IPC, Click here
Compiled by:
Rakesh Dahiya, SDCO cum Licensing Authority, FDA Haryana
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
